Categorizing weight growth of infants born before 32 weeks' gestation using the 2023 postnatal growth charts for

Fu-Sheng Chou1,2,3,4, Hung-Wen Yeh5,6, Crystal Hsueh7

  • 1Southern California Permanente Medical Group, Pasadena, CA, USA. Fu-Sheng.X.Chou@kp.org.

Insights

This study categorizes infant growth using new charts, finding both slow and fast weight gain in preterm infants are linked to health issues like bronchopulmonary dysplasia.

Area of Science:

  • Neonatalogy
  • Pediatric Growth Monitoring
  • Infant Health Outcomes

Background:

  • Premature infants (born before 32 weeks gestation) require precise growth monitoring.
  • Existing growth charts may not fully capture the nuances of growth in this vulnerable population.
  • Understanding growth patterns is crucial for identifying potential health risks.

Purpose of the Study:

  • To establish distinct weight growth categories for preterm infants.
  • To correlate these growth categories with the incidence of specific morbidities.
  • To introduce an alternative method for assessing infant growth using updated charts.

Main Methods:

  • A retrospective study utilizing the 2023 Postnatal Growth Charts for Preterm Infants.
  • Weight growth was categorized by correlating mean growth velocity (GV) with growth trajectory z-score changes (ΔGTZ).
  • Associations between categorized weight growth and infant morbidities were analyzed.

Main Results:

  • Three growth categories were defined: slower (ΔGTZ < -0.1), in-parallel (-0.1 to 0.3), and faster (ΔGTZ > 0.3).
  • Both slower and faster growth patterns were significantly associated with bronchopulmonary dysplasia.
  • Slower growth was uniquely associated with retinopathy of prematurity.

Conclusions:

  • The 2023 Postnatal Growth Charts for Preterm Infants offer a novel approach to categorizing infant weight growth.
  • This categorization method aids in identifying preterm infants at higher risk for specific morbidities.
  • The findings highlight the complex relationship between growth trajectories and health outcomes in extremely preterm infants.
Abstract

Related Concept Videos

z Scores and Area Under the Curve01:17

z Scores and Area Under the Curve

z scores are the standardized values obtained after converting a normal distribution into a standard normal distribution. A z score is measured in units of the standard deviation. The z score tells you how many standard deviations the value x is above (to the right of) or below (to the left of) the mean, μ. Values of x that are larger than the mean have positive z scores, and values of x that are smaller than the mean have negative z scores. If x equals the mean, then x has a z score of...
11.3K
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.5K
Oxygen Requirements and Growth Patterns01:29

Oxygen Requirements and Growth Patterns

Microorganisms exhibit diverse oxygen requirements and growth patterns driven by their metabolic strategies and environmental adaptations. Oxygen, while essential for many organisms, can also be toxic under certain conditions, shaping how microorganisms grow and survive.Oxygen Requirements of MicroorganismsMicroorganisms are classified based on their ability to use or tolerate oxygen:● Obligate aerobes like Mycobacterium tuberculosis need oxygen for energy production, as it serves as the...
238
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
20.8K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.8K